miR-30b-5p inhibits proliferation, invasion, and migration of papillary thyroid cancer by targeting GALNT7 via the EGFR/PI3K/AKT pathway.

Wang, Ye; Wang, Congjun; Fu, Zhao; Zhang, Siwen; Chen, Junqiang

Wang, Ye; Wang, Congjun; Fu, Zhao; Zhang, Siwen; Chen, Junqiang.

Afiliación

Wang Y; The First Affiliated Hospital of Guangxi Medical University, Department of Gastrointestinal Gland Surgery, Nanning, 530021, Guangxi, China.
Wang C; Guangxi Medical University, Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, Nanning, 530021, Guangxi, China.
Fu Z; The First Affiliated Hospital of Guangxi Medical University, Department of Gastrointestinal Gland Surgery, Nanning, 530021, Guangxi, China.
Zhang S; Guangxi Medical University, Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, Nanning, 530021, Guangxi, China.
Chen J; The First Affiliated Hospital of Guangxi Medical University, Department of Gastrointestinal Gland Surgery, Nanning, 530021, Guangxi, China.

Cancer Cell Int ; 21(1): 618, 2021 Nov 24.

Article en En | MEDLINE | ID: mdl-34819077

Palabras clave

GALNT7; Papillary thyroid carcinoma; Progression; The EGFR/PI3K/AKT pathway; miR-30b-5p

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Cancer Cell Int Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google